Trafalgar International (GCAN) Retained Earnings (2016 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Retained Earnings of $2.9 million for Q1 2026, up 158.97% year-over-year from $1.1 million in Q1 2025, and up 157.92% quarter-over-quarter from -$5.0 million in Q4 2025.
Trafalgar International (GCAN) Retained Earnings (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Retained Earnings history runs 11 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 158.97% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 158.97% YoY), while the FY2025 annual figure was -$5.0 million, down 266.05% from the prior year.
- Retained Earnings for Q1 2026 stood at $2.9 million, up from -$5.0 million in the prior quarter.
- The five-year high for Retained Earnings was $3.0 million in Q3 2022, with the low at -$5.0 million in Q4 2025.
- The 5-year median for Retained Earnings is $2.9 million (2026), against an average of $304729.2.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings jumped 185.51% in 2022, then plunged 266.05% in 2025.
- Greater Cannabis Company's Retained Earnings stood at $3.0 million in 2022, then slumped by 249.06% to -$4.5 million in 2023, then surged by 167.09% to $3.0 million in 2024, then slumped by 266.05% to -$5.0 million in 2025, then soared by 157.92% to $2.9 million in 2026.
- Business Quant data shows GCAN's Retained Earnings at $2.9 million in Q1 2026, -$5.0 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | -5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | -4.99 Mn |
| Sep 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 2.86 Mn |
| Mar 31, 2025 | -4.90 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | 3.01 Mn |
| Mar 31, 2024 | -4.53 Mn |
| Dec 31, 2023 | -4.48 Mn |
| Sep 30, 2023 | 3.01 Mn |
| Jun 30, 2023 | -4.38 Mn |
| Mar 31, 2023 | 3.01 Mn |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | 3.01 Mn |
| Jun 30, 2022 | -4.14 Mn |
| Mar 31, 2022 | 2.95 Mn |
| Dec 31, 2021 | -3.93 Mn |
| Sep 30, 2021 | 2.95 Mn |
| Jun 30, 2021 | -3.48 Mn |